Increase in NKT Cells – A Marker of Early Progressing at Adjuvantvaccinotherapy of Patients With a Metastatic Melanoma of Skin

Russian Journal of Biotherapy
doi 10.17650/1726-9784-2019-18-4-82-89
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Publishing House ABV Press

Related search

CTLA4 Blockade Increases Th17 Cells in Patients With Metastatic Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2009English

ABCB1 Identifies a Subpopulation of Uveal Melanoma Cells With High Metastatic Propensity

Pigment Cell and Melanoma Research
BiochemistryDermatologyOncologyGeneticsMolecular Biology
2011English

Imaging Pattern of Radiolabelled Lymphokine-Activated Killer Cells in Patients With Metastatic Malignant Melanoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
1991English

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma

Cancers
Cancer ResearchOncology
2019English

A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells

PLoS ONE
Multidisciplinary
2009English

BRAF G596R Mutation in a Slow-Progressing Melanoma

Pathology and Laboratory Medicine International
2015English

Immunosuppressive Roles of Natural Killer T (NKT) Cells in the Skin

Journal of Leukocyte Biology
AllergyImmunologyCell Biology
2014English

Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients With Metastatic Melanoma: Predictive Importance of Induced Early Hypertension

PLoS ONE
Multidisciplinary
2012English

Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma

Cancer immunology research
Cancer ResearchImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy